Ligand‑Based Virtual Screening Discovery of Thienopyrimidinone Derivatives as Allosteric nSMase2 Modulators and Antivirals Against West Nile Virus
ChemMedChem · 2026
DOI: 10.1002/cmdc.70452 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, 2026. Verfasst von Hadrián Álvarez-Fernández und 6 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Química Médica y Biomedicina (IQMB CSIC), Madrid, Spain. Hauptthemen laut MEDLINE: West Nile virus, Antiviral Agents, Pyrimidinones, Enzyme Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MCIN/AEI.
Abstract (Originalsprache)
Orthoflaviviruses such as West Nile virus (WNV), Zika virus (ZIKV), or dengue virus (DENV) represent a growing global health threat, with millions of annual infections and no approved antiviral therapies. Targeting host pathways represents an alternative antiviral strategy that may overcome limitations associated with direct‐acting antivirals, including resistance and narrow antiviral spectra. Neutral sphingomyelinase‐2 (nSMase2) plays a central role in sphingolipid metabolism and has emerged as a host factor involved in the replication of several flaviviruses including WNV and ZIKV. Herein, we report a new family of thienopyrimidinone derivatives as nSMase2 inhibitors. A ligand‐based virtual screening (LBVS) campaign using DPTIP as a template ligand identified 13 candidates from over 5 million ZINC20 compounds, which were refined through ADMET‐properties prediction and molecular docking. Experimental evaluation identified compound 16 as a novel nSMase2 inhibitor. Rational design guided by computational affinity maps enabled the synthesis of several derivatives bearing a thienopyrimidinone core. These compounds inhibited nSMase2 and showed antiviral activity against WNV in cell‑based assays. These results identify thienopyrimidinone derivatives as a new scaffold for nSMase2 inhibition and support host‐directed modulation of sphingolipid metabolism as a promising strategy for the development of broad‐spectrum antivirals against flaviviruses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Instituto de Química Médica y Biomedicina (IQMB CSIC), Madrid, Spain.
- Departamento de Biotecnología, Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA CSIC), Madrid, Spain.
ORCID-Profile: Patricia Mingo-Casas, Ana-Belén Blázquez, Miguel A Martín-Acebes, María-Jesús Pérez-Pérez, Eva-María Priego
Förderung
- MCIN/AEI
Zitieren
APA
Álvarez-Fernández, H., Mingo-Casas, P., Blázquez, A. B., Caridi, F., Martín-Acebes, M. A., Pérez-Pérez, M. J., & Priego, E. M. (2026). Ligand‑Based Virtual Screening Discovery of Thienopyrimidinone Derivatives as Allosteric nSMase2 Modulators and Antivirals Against West Nile Virus. ChemMedChem. https://doi.org/10.1002/cmdc.70452
Vancouver
Álvarez-Fernández H, Mingo-Casas P, Blázquez AB, Caridi F, Martín-Acebes MA, Pérez-Pérez MJ, et al. Ligand‑Based Virtual Screening Discovery of Thienopyrimidinone Derivatives as Allosteric nSMase2 Modulators and Antivirals Against West Nile Virus. ChemMedChem. 2026. doi:10.1002/cmdc.70452
BibTeX
@article{lvarezFernndez2026,
author = {Álvarez-Fernández, Hadrián and Mingo-Casas, Patricia and Blázquez, Ana-Belén and Caridi, Flavia and Martín-Acebes, Miguel A and Pérez-Pérez, María-Jesús and Priego, Eva-María},
title = {Ligand‑Based Virtual Screening Discovery of Thienopyrimidinone Derivatives as Allosteric nSMase2 Modulators and Antivirals Against West Nile Virus},
journal = {ChemMedChem},
year = {2026},
doi = {10.1002/cmdc.70452}
}
EUVIMED